{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:56:24Z","timestamp":1762005384459,"version":"3.37.3"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00277-022-04790-2","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T12:02:22Z","timestamp":1644667342000},"page":"1595-1596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anhidrosis associated with long-term use of hydroxyurea in a patient with myeloproliferative neoplasm"],"prefix":"10.1007","volume":"101","author":[{"given":"Saad","family":"Sabbagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawthar","family":"Jarrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan","family":"Bou-Fakhredin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Saadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8515-2238","authenticated-orcid":false,"given":"Ali T.","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,12]]},"reference":[{"issue":"11","key":"4790_CR1","doi-asserted-by":"crossref","first-page":"13030\/qt8h64503","DOI":"10.5070\/D32311037268","volume":"23","author":"B Neill","year":"2017","unstructured":"Neill B, Ryser T, Neill J, Aires D, Rajpara A (2017) A patient case highlighting the myriad of cutaneous adverse effects of prolonged use of hydroxyurea. Dermatol Online J 23(11):13030\/qt8h64503t","journal-title":"Dermatol Online J"},{"issue":"8","key":"4790_CR2","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3889\/oamjms.2018.320","volume":"6","author":"V Simeonovski","year":"2018","unstructured":"Simeonovski V, Breshkovska H, Duma S, Dohcheva-Karajovanov I, Damevska K, Nikolovska S (2018) Hydroxyurea associated cutaneous lesions: a case report. Open Access Maced J Med Sci 6(8):1458\u20131461. https:\/\/doi.org\/10.3889\/oamjms.2018.320","journal-title":"Open Access Maced J Med Sci"},{"issue":"4","key":"4790_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-2257.2000.00311.x","volume":"22","author":"HS Young","year":"2000","unstructured":"Young HS, Khan AS, Kendra JR, Coulson IH (2000) The cutaneous side-effects of hydroxyurea. Clin Lab Haematol 22(4):229\u2013232. https:\/\/doi.org\/10.1046\/j.1365-2257.2000.00311.x","journal-title":"Clin Lab Haematol"},{"issue":"9","key":"4790_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ajh.23698","volume":"89","author":"D Butler","year":"2014","unstructured":"Butler D, Nambudiri VE, Nandi T (2014) Hydroxyurea-associated acral erythema in a patient with polycythemia vera. Am J Hematol 89(9):931\u2013932. https:\/\/doi.org\/10.1002\/ajh.23698","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"4790_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/jdv.17406","volume":"36","author":"T Gambichler","year":"2022","unstructured":"Gambichler T, Stockfleth E, Susok L (2022) Aggressive cutaneous squamous cell carcinoma in a hydroxyurea- and ruxolitinib-pretreated patient with polycythaemia vera. J Eur Acad Dermatol Venereol: JEADV 36(Suppl 1):63\u201365. https:\/\/doi.org\/10.1111\/jdv.17406","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"key":"4790_CR6","doi-asserted-by":"publisher","unstructured":"Stegelmann F, Wille K, Busen H et al (2021) Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) \u2013 on behalf of the German Study Group-MPN. Leukemia 35(2):628\u2013631. https:\/\/doi.org\/10.1038\/s41375-020-0945-3","DOI":"10.1038\/s41375-020-0945-3"},{"key":"4790_CR7","unstructured":"Takagi K, Nakamura T, Misaki H, Ueda T (2000) [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia]. Rinsho Ketsueki. 41(11):1214\u20139. Japanese"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T18:46:49Z","timestamp":1674758809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,12]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4790"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04790-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2022,2,12]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patient gave informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}